Kenvueは現在、以下求人を募集しております。
私たちがしていること
私たちは、日々のケアが持つ驚くべき力を信じています。100年以上の伝統と科学に根ざし、Neutrogena®, Aveeno®, Tylenol®, Listerine®, Johnson’s® and BAND-AID® など、皆様が既にご存じでご愛用いただいているアイコニックなブランドを提供しています。科学は私たちの情熱であり、ケアは私たちの才能です。
Who We Are
私たちのグローバルチームは、インサイトとイノベーションに情熱を注ぎ、最高の製品をお客様にお届けすることに全力を注ぐ、多様で優秀な22,000人以上の社員で構成されています。専門知識と共感力を備えたKenvuerであることは、毎日何百万人もの人々の生活に影響を与える力を持つことを意味します。私たちは、人を第一に考え、全身全霊をもってケアし、サイエンスで信頼を獲得し、勇気をもって解決します。私たちとあなた自身の未来を、共に切り開いていきましょう。
Role reports to
CIENTISTA ESP
場所
Latin America, Brazil, Sao Paulo, Sao Jose dos Campos
勤務地
ハイブリッド
あなたがすること
The R&D Analytical Senior Scientist is responsible for delivering analytical projects for the Self-Care portfolio (Drug Products), supporting Latin America at both local and regional levels.
This individual will independently lead the execution of analytical activities related to test method development and validation, will also write and review technical documents, including analytical method assessments, method validation/transfer protocols and reports, applied statistics, and GMP documentation. This individual will also be responsible for transferring test methods to the quality control laboratory and leading laboratory activities related to troubleshooting, laboratory investigations, and material characterization, as well as performing analyses and independently operating equipment such as HPLC/UPLC and GC-FID, among others.
Key Responsibilities
- Lead the execution of stability studies, method development, validation, and method transfer to the quality control laboratory, and support related activities (test method creation/revision, change controls, investigation support, etc.)
- Write and review technical documents including analytical method assessments, validation protocols and validation reports in accordance with standard operating procedures and regulatory requirements;
- Conduct analyses for development and stability studies, including critical evaluation of results;
- Represent the team in analytical and technical discussions;
- Communicate clearly with the internal organization (Kenvue Self Care related areas – Regulatory, Product Development, Quality & Compliance, etc.);
- Collaborate effectively with project members following priorities, checkpoints, and timelines to support milestones;
- Communicate issues that require escalation;
- Demonstrate a sense of urgency in actively responding to problems and opportunities.
What we are looking for
Required Qualifications
- Bachelor’s degree in Pharmacy, Chemistry, Chemical Engineering, or related fields; postgraduate education in Analytical Development/Validation or Quality Assurance is a plus. (Aligned with ANVISA GMP requirements for qualified personnel);
- Proficiency in HPLC/UPLC, GC, USP dissolution systems, data integrity systems and LIMS/ELN.
- Validation and verification of analytical methods (HPLC/UPLC, GC, UV/Vis, IR) according to RDC 166/2017 (selectivity, linearity, range, accuracy, precision, LOD/LOQ, robustness, matrix effect, method transfer, and revalidation). Extensive expertise in method validation and method transfer execution;
- Stability studies (accelerated, long‑term, and follow‑up) according to RDC 318/2019.
- GMP compliance: Documentation, data integrity, CAPA, change control, audits.
- Use of official compendia, especially the USP, Brazilian, and FEUM pharmacopoeias.
- Ability to work independently and in a team environment;
- Intermediate level of English (oral and written communication).
Desired Qualifications
- Development and validation of dissolution methods for oral solid dosage forms, according to the Dissolution Guide – ANVISA Guide nº14/2021 v2 (medium selection, apparatus, agitation, temperature, discriminative power, and acceptance criteria).
- Forced degradation studies and establishment of degradation profiles and mass balance, aligned with ICH Q1A(R2) and Brazilian requirements for degradation products.
- Impurity control and risk assessment, including:
- Elemental impurities per ICH Q3D(R2);
- Degradation products under the national regulatory framework (RDC 964/2025 — RDC 821/2023 and IN 258/2023 and annex).
障害のある個人の方は、宿泊施設のリクエスト方法について障害支援ページを確認してください。